Executable code: what, why and how

ISSN： 1757-093X

Source： Pharmaceutical Programming, Vol.5, Iss.1-2, 2012-12, pp. : 65-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bioequivalence: How, Why, and What Does it Really Mean?

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 3, 2004-09 ,pp. : 195-200

John Wiley & Sons Inc

Access to resources Recommend Favorite

What they are, How they Work and Why they do What they do? The Story of SV40-derived Gene Therapy Vectors and What They Have to Offer

Current Gene Therapy, Vol. 5, Iss. 2, 2005-04 ,pp. : 151-165

Bentham Science Publishers

Access to resources Recommend Favorite

Predicting Drug-Likeness: Why and How ?

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 12, 2002-12 ,pp. : 1273-1286

Bentham Science Publishers

Access to resources Recommend Favorite

A curriculum for SHO training – what is it and why has it changed?

By Carty E Neville E Pembroke M A Wade W B

Clinical Medicine, Vol. 1, Iss. 1, 2001-01 ,pp. : 50-53

Royal College Of Physicians

Access to resources Recommend Favorite

Variability in susceptibility - how big, how often, for what responses to what agents?

By Hattis D.

Environmental Toxicology and Pharmacology, Vol. 2, Iss. 2, 1996-10 ,pp. : 135-145

Elsevier

Access to resources Recommend Favorite